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SThe crisis of readmissions: Symptom or disease?Varun Puri, MD, MSCIUnexpected readmission after major lung resection is a rela-
tively common occurrence and a major financial burden to
the health care system. Although no clear data on lung cancer
surgery are available, the Center for Medicare and MedicaidServices estimates its annual costs for 30-day readmission to
hospitals to be $26 billion.1 As Hu and colleagues have
shown in their article in this issue of the Journal, the overall
long-term burden to society goes well beyond direct costs,
because readmissions are associated with a significantly
elevated risk of 90-day mortality. As part of the Affordable
Care Act’s Hospital Readmissions Reduction Program, pub-
lic reporting of readmission rates has now been mandated,
with potential financial penalties for institutions with exces-
sive readmissions. Thus without a doubt preventing and
appropriately managing readmissions in thoracic surgery is
not only a medical necessity but a financial imperative for
programs. This is especially true because competing nonop-
erative techniques for treating lung cancer are almost entirely
free from the burden of readmissions.
Hu and colleagues, as well as previous authors, have
treated readmission both as an important outcome variable
in and of itself and as a predictor variable for further
downstream events (death, disability, etc). For statisticaldiovascular Surgery c Volume 148, Number 5 2267
Editorial Commentary Puri
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Smodeling, this approach is indeed understandable and
appropriate. One must understand, however, that readmis-
sion is not a diagnosis but a sentinel event that is a marker
of underlying medical and sometimes social conditions
necessitating further contact with the health care system.
Thus our goal should be to manage the issues leading to
readmission. This is important, because an overemphasis
on simply reducing readmission rates to avoid incurring
penalties may lead to reluctance to readmit, with disastrous
medical consequences.
An important finding of the study Hu and colleagues, also
been reported by others, is that single-institution data miss
at least 25% of readmissions. This may be especially true of
larger academic programs, where patients travel consider-
able distances to get surgical care. On the other hand, it is
also important to distinguish planned (unrelated) and un-
planned readmissions. A patient with stage III lung cancer
may undergo placement of venous access for chemotherapy
after surgery and be recorded as a readmission in large da-
tabases. Additionally, the average patient with lung cancer
has significant comorbidities that can lead to unrelated ad-
missions to the hospital shortly after surgery. Nevertheless,
the current enhanced scrutiny of the national ‘‘readmission
crisis’’ calls for a 3-pronged approach to the problem: pre-
dict, avoid, and manage.
Patient-related factors associated with readmission
include increasing age, male sex, lower socioeconomic sta-
tus, and higher levels of comorbidity.2 More complex oper-
ations, such as pneumonectomy and chest wall resection, are
also risk factors. Finally, higher stage of cancer, a longer in-
dex hospitalization, and major postoperative complications
are predictive of readmissions as well. Despite these recog-
nized predisposing factors, the models developed to predict
readmission after major cardiothoracic surgery have very
modest discrimination (C statistic around 0.6), with a pre-
dictive ability only slightly greater than chance. This high-
lights a significant drawback of studies that use large data
sets in which pertinent patient-specific information likely
to impact readmission rates, such as lung function tests or
functional status, is unavailable. Additionally, none of the
available models account for the patient’s home support or
the social circumstances at the time of discharge. Undoubt-
edly, future studies conducted with more granular informa-
tion, possibly from clinical consortiums, will further refine
these models to make them clinically meaningful.2268 The Journal of Thoracic and Cardiovascular SurMore than 40 clinical trials have studied strategies to pre-
vent readmissions, with modest overall success.3 Interven-
tions studied range from enhanced discharge planning to
increasing home-based support or even telemonitoring.
Interventions with many components (bundles of care),
those involving more individuals in care delivery (larger
and more diverse health care teams), and those supporting
patient capacity for self-care have had the most consistent
success. Although most subjects studied are medical pa-
tients, the lessons learned are likely applicable in postoper-
ative care. A number of groups have introduced fast-tracking
protocols for lung cancer resection by implementing intrao-
perative and postoperative standardized care pathways.
These measures include avoidance and prompt management
of air leaks, early ambulation, vigilance in detecting and
managing common postoperative complications, and, most
importantly a well-organized team approach. Fast-track
management pathways have successfully shortened stays
while maintaining equivalent or even lower readmission
rates.4 A much less discussed issue is patient education
and preparation before surgery. Setting realistic expectations
for the postoperative period can likely avoid some of the re-
admissions for such issues as postoperative pain, drain man-
agement, and wound care.
Finally, timely and appropriate care of readmitted patients
should be an absolute priority in the postoperative period.
Because circumstances of readmissions vary, few general-
izations can be made, other than a recommendation for
appropriate resource allocation. A well-managed readmis-
sion can be considered a ‘‘save,’’ and despite the associated
financial burden to the health care system, it remains our
foremost ethical obligation to care for individuals with
hospital-acquired conditions.References
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